Penny stocks are incredibly dangerous investments that can burn new and seasoned investors alike. InvestorPlace’s best micro-cap analysts recommend buying penny stocks, or cheap stocks, only with the strictest of warnings. But while pink sheet stocks can be halved in the blink of an eye, they can also double much quicker than large-cap stocks.
Progenity has a plan in place to save $97 million a year, but how fast can they pull it off, and will it be enough to save PROG stock?
With so much chaos occurring on Wall Street, these lesser-known penny stocks to buy might fly profitably under the radar.
The Metals Company is down 70% since mid-September. But there are some reasons to consider if you're taking a position in TMC stock.
TELL stock has become a meme play as Tellurian seeks capital to build an LNG export terminal near Lake Charles, Louisiana.
SOLO stock has been stuck in third gear lately, but the urban driving experience is quickly evolving with new EV commercial deliveries.
So, which penny stocks should you buy, with the potential to break through the ceiling, en route to higher prices? Consider these seven top names that could do just that: Cinedigm (NASDAQ:CIDM) Vaalco Energy (NYSE:EGY) Globalstar (NYSEAMERICAN:GSAT) Mind Medicine (NASDAQ:MNMD) Romeo Power (NYSE:RMO) Senseonics (NYSEAMERICAN:SENS) Uranium Energy (NYSEAMERICAN:UEC)
SENS stock should follow a similar trajectory to DexCom, and if it does, it will likely explode in price following FDA approval.
As a short seller levies a broadside against CEI stock, investors should carefully review the facts before deciding the fate of their shares.
Several penny stocks out there have done very well recently but these three biotechs are waiting for positive FDA news to soar higher.
Meta Materials acquired a Canadian company specializing in nano-imprint technology. It will have to do still more to justify a $5 per share valuation on MMAT stock.
Penny stocks have tons of upside and tons of risk. These seven are NYSE listed, making them safer but not dulling their upside potential.
Penny stocks carry risk, but they offer substantial upside considering they trade at very conservative price multiples versus growth stocks.
With a new year fast approaching, these biotech penny stocks may benefit from the shifting winds in the broader healthcare market.
While the surface-level narrative for RWLK stock is exceptionally compelling, the science and the economics are questionable.
While a C-suite scenery change might be good for Zomedica, the shift may not provide a similar outcome for ZOM stock.
These penny stocks have huge potential and solid business fundamentals. As not-so speculative names, they could surge higher sooner or later.
Even with the rise of oil prices, Camber Energy ought to be permanently off-limits to oil and gas investors. Stay away from CEI stock.
They're not exactly names you want to bet the ranch on. Still, a $100 position in each of these penny stocks could be worth the risk.
With the Biden administration struggling, those who want to speculate on SNDL stock should consider how it would fare under Trump.
After a rough 2020, Sundial Growers emerged as a stronger company, with a dual strategy that makes SNDL stock a promising speculative play.